-
1
-
-
3042699971
-
American Diabetes Association: Nephropathy in diabetes
-
MolitchME, DeFronzo RA, FranzMJ, KeaneWF,Mogensen CE, Parving HH, Steffes MW; American Diabetes Association: Nephropathy in diabetes. Diabetes Care 27[Suppl 1]: S79-S83, 2004
-
(2004)
Diabetes Care
, vol.27
, pp. S79-S83
-
-
Molitch, M.E.1
Defronzo, R.A.2
Franz, M.J.3
Keane, W.F.4
Mogensen, C.E.5
Parving, H.H.6
Steffes, M.W.7
-
2
-
-
65449151412
-
Therapies for hyperglycaemia-induced diabetic complications: From animal models to clinical trials
-
Calcutt NA, Cooper ME, Kern TS, Schmidt AM: Therapies for hyperglycaemia-induced diabetic complications: From animal models to clinical trials. Nat Rev Drug Discov 8: 417-429, 2009
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 417-429
-
-
Calcutt, N.A.1
Cooper, M.E.2
Kern, T.S.3
Schmidt, A.M.4
-
4
-
-
0141755311
-
Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy
-
Kitada M, Koya D, Sugimoto T, Isono M, Araki S, Kashiwagi A, Haneda M: Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 52: 2603-2614, 2003
-
(2003)
Diabetes
, vol.52
, pp. 2603-2614
-
-
Kitada, M.1
Koya, D.2
Sugimoto, T.3
Isono, M.4
Araki, S.5
Kashiwagi, A.6
Haneda, M.7
-
5
-
-
21044436751
-
NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy
-
SatohM, Fujimoto S, Haruna Y, Arakawa S, Horike H, KomaiN, Sasaki T, Tsujioka K, Makino H, Kashihara N: NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 288: F1144-F1152, 2005
-
(2005)
Am J Physiol Renal Physiol
, vol.288
, pp. F1144-F1152
-
-
Satohm Fujimoto, S.1
Haruna, Y.2
Arakawa, S.3
Horike, H.4
Komain Sasaki, T.5
Tsujioka, K.6
Makino, H.7
Kashihara, N.8
-
6
-
-
33644783770
-
Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy
-
Susztak K, Raff AC, Schiffer M, Böttinger EP: Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55: 225-233, 2006
-
(2006)
Diabetes
, vol.55
, pp. 225-233
-
-
Susztak, K.1
Raff, A.C.2
Schiffer, M.3
Böttinger, E.P.4
-
7
-
-
63849160230
-
Molecular mechanisms of hypertension: Role ofNox family NADPH oxidases
-
Sedeek M, Hébert RL, Kennedy CR, Burns KD, Touyz RM: Molecular mechanisms of hypertension: Role ofNox family NADPH oxidases. Curr Opin Nephrol Hypertens 18: 122-127, 2009
-
(2009)
Curr Opin Nephrol Hypertens
, vol.18
, pp. 122-127
-
-
Sedeek, M.1
Hébert, R.L.2
Kennedy, C.R.3
Burns, K.D.4
Touyz, R.M.5
-
8
-
-
84871819023
-
Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes
-
Sedeek M, Gutsol A, Montezano AC, Burger D, Nguyen Dinh Cat A, Kennedy CR, Burns KD, Cooper ME, Jandeleit-Dahm K, Page P, Szyndralewiez C, Heitz F, Hebert RL, Touyz RM: Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. Clin Sci (Lond) 124: 191-202, 2013
-
(2013)
Clin Sci (Lond)
, vol.124
, pp. 191-202
-
-
Sedeek, M.1
Gutsol, A.2
Montezano, A.C.3
Burger, D.4
Nguyen Dinh Cat, A.5
Kennedy, C.R.6
Burns, K.D.7
Cooper, M.E.8
Jandeleit-Dahm, K.9
Page, P.10
Szyndralewiez, C.11
Heitz, F.12
Hebert, R.L.13
Touyz, R.M.14
-
9
-
-
56149093044
-
NADPH oxidases in the vasculature:Molecular features, roles in disease and pharmacological inhibition
-
Selemidis S, Sobey CG, Wingler K, Schmidt HH, Drummond GR: NADPH oxidases in the vasculature:Molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 120: 254-291, 2008
-
(2008)
Pharmacol Ther
, vol.120
, pp. 254-291
-
-
Selemidis, S.1
Sobey, C.G.2
Wingler, K.3
Schmidt, H.H.4
Drummond, G.R.5
-
10
-
-
79957890774
-
NOX1, 2, 4, 5: Counting out oxidative stress
-
Wingler K, Hermans JJ, Schiffers P, Moens A, Paul M, Schmidt HH: NOX1, 2, 4, 5: Counting out oxidative stress. Br J Pharmacol 164: 866-883, 2011
-
(2011)
Br J Pharmacol
, vol.164
, pp. 866-883
-
-
Wingler, K.1
Hermans, J.J.2
Schiffers, P.3
Moens, A.4
Paul, M.5
Schmidt, H.H.6
-
11
-
-
0042864155
-
Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment
-
Etoh T, Inoguchi T, Kakimoto M, Sonoda N, Kobayashi K, Kuroda J, Sumimoto H, Nawata H: Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia 46: 1428-1437, 2003
-
(2003)
Diabetologia
, vol.46
, pp. 1428-1437
-
-
Etoh, T.1
Inoguchi, T.2
Kakimoto, M.3
Sonoda, N.4
Kobayashi, K.5
Kuroda, J.6
Sumimoto, H.7
Nawata, H.8
-
12
-
-
77956493744
-
The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse
-
Giunti S, Calkin AC, Forbes JM, Allen TJ, Thomas MC, Cooper ME, Jandeleit-DahmKA: The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse. Am J Physiol Renal Physiol 299: F528-F535, 2010
-
(2010)
Am J Physiol Renal Physiol
, vol.299
, pp. F528-F535
-
-
Giunti, S.1
Calkin, A.C.2
Forbes, J.M.3
Allen, T.J.4
Thomas, M.C.5
Cooper, M.E.6
Jandeleit-Dahm, K.A.7
-
13
-
-
33845522286
-
Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice
-
Ohshiro Y,Ma RC, Yasuda Y,Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL: Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Diabetes 55: 3112-3120, 2006
-
(2006)
Diabetes
, vol.55
, pp. 3112-3120
-
-
Ohshiro Yma, R.C.1
Yasuda, Y.2
Hiraoka-Yamamoto, J.3
Clermont, A.C.4
Isshiki, K.5
Yagi, K.6
Arikawa, E.7
Kern, T.S.8
King, G.L.9
-
14
-
-
84877270825
-
NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis
-
Gray SP, Di Marco E, Okabe J, Szyndralewiez C, Heitz F, Montezano AC, de Haan JB, Koulis C, El-Osta A, Andrews KL, Chin-Dusting JP, Touyz RM, Wingler K, Cooper ME, Schmidt HH, Jandeleit-Dahm KA: NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation 127: 1888-1902, 2013
-
(2013)
Circulation
, vol.127
, pp. 1888-1902
-
-
Gray, S.P.1
Di Marco, E.2
Okabe, J.3
Szyndralewiez, C.4
Heitz, F.5
Montezano, A.C.6
De Haan, J.B.7
Koulis, C.8
El-Osta, A.9
Andrews, K.L.10
Chin-Dusting, J.P.11
Touyz, R.M.12
Wingler, K.13
Cooper, M.E.14
Schmidt, H.H.15
Jandeleit-Dahm, K.A.16
-
15
-
-
70149091965
-
Subcellular localization of Nox4 and regulation in diabetes
-
Block K, Gorin Y, Abboud HE: Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci U S A 106: 14385-14390, 2009
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 14385-14390
-
-
Block, K.1
Gorin, Y.2
Abboud, H.E.3
-
16
-
-
0034608934
-
Identification of renox, an NAD(P)H oxidase in kidney
-
Geiszt M, Kopp JB, Várnai P, Leto TL: Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 97: 8010-8014, 2000
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 8010-8014
-
-
Geiszt, M.1
Kopp, J.B.2
Várnai, P.3
Leto, T.L.4
-
17
-
-
84877046009
-
Nox4 and diabetic nephropathy:With a friend like this, who needs enemies?
-
Gorin Y, Block K:Nox4 and diabetic nephropathy:With a friend like this, who needs enemies? Free Radic Biol Med 61C: 130-142, 2013
-
(2013)
Free Radic Biol Med
, vol.61 C
, pp. 130-142
-
-
Gorin, Y.1
Block, K.2
-
18
-
-
0035847051
-
A novel superoxide-producing NAD(P)H oxidase in kidney
-
Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakata H, Naito S, Hattori M, Sakaki Y, Sumimoto H: A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem276: 1417-1423, 2001
-
(2001)
J Biol Chem
, vol.276
, pp. 1417-1423
-
-
Shiose, A.1
Kuroda, J.2
Tsuruya, K.3
Hirai, M.4
Hirakata, H.5
Naito, S.6
Hattori, M.7
Sakaki, Y.8
Sumimoto, H.9
-
19
-
-
28044455523
-
Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney
-
Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE: Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280: 39616-39626, 2005
-
(2005)
J Biol Chem
, vol.280
, pp. 39616-39626
-
-
Gorin, Y.1
Block, K.2
Hernandez, J.3
Bhandari, B.4
Wagner, B.5
Barnes, J.L.6
Abboud, H.E.7
-
20
-
-
84864414285
-
Role of Nox4 in murine models of kidney disease
-
Babelova A, Avaniadi D, Jung O, Fork C, Beckmann J, Kosowski J, Weissmann N, Anilkumar N, Shah AM, Schaefer L, Schröder K, Brandes RP: Role of Nox4 in murine models of kidney disease. Free Radic Biol Med 53: 842-853, 2012
-
(2012)
Free Radic Biol Med
, vol.53
, pp. 842-853
-
-
Babelova, A.1
Avaniadi, D.2
Jung, O.3
Fork, C.4
Beckmann, J.5
Kosowski, J.6
Weissmann, N.7
Anilkumar, N.8
Shah, A.M.9
Schaefer, L.10
Schröder, K.11
Brandes, R.P.12
-
21
-
-
84870496327
-
NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury
-
Nlandu Khodo S, Dizin E, Sossauer G, Szanto I, Martin PY, Feraille E, Krause KH, de Seigneux S: NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury. J Am Soc Nephrol 23: 1967-1976, 2012
-
(2012)
J Am Soc Nephrol
, vol.23
, pp. 1967-1976
-
-
Nlandu Khodo, S.1
Dizin, E.2
Sossauer, G.3
Szanto, I.4
Martin, P.Y.5
Feraille, E.6
Krause, K.H.7
De Seigneux, S.8
-
22
-
-
84866950669
-
Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent
-
Aoyama T, Paik YH, Watanabe S, Laleu B, Gaggini F, Fioraso-Cartier L, Molango S, Heitz F, Merlot C, Szyndralewiez C, Page P, Brenner DA: Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology 56: 2316-2327, 2012
-
(2012)
Hepatology
, vol.56
, pp. 2316-2327
-
-
Aoyama, T.1
Paik, Y.H.2
Watanabe, S.3
Laleu, B.4
Gaggini, F.5
Fioraso-Cartier, L.6
Molango, S.7
Heitz, F.8
Merlot, C.9
Szyndralewiez, C.10
Page, P.11
Brenner, D.A.12
-
23
-
-
0032712434
-
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
-
CooperME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, Casley DJ, Bach LA, KellyDJ,Gilbert RE: Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48: 2229-2239, 1999
-
(1999)
Diabetes
, vol.48
, pp. 2229-2239
-
-
Cooperme Vranes, D.1
Youssef, S.2
Stacker, S.A.3
Cox, A.J.4
Rizkalla, B.5
Casley, D.J.6
Bach, L.A.7
Kellydjgilbert, R.E.8
-
24
-
-
52049110957
-
Assessment of superoxide production and NADPH oxidase activity by HPLC analysis of dihydroethidium oxidation products
-
Laurindo FR, Fernandes DC, Santos CX: Assessment of superoxide production and NADPH oxidase activity by HPLC analysis of dihydroethidium oxidation products. Methods Enzymol 441: 237-260, 2008
-
(2008)
Methods Enzymol
, vol.441
, pp. 237-260
-
-
Laurindo, F.R.1
Fernandes, D.C.2
Santos, C.X.3
-
25
-
-
30944456936
-
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice
-
Chow FY, Nikolic-Paterson DJ,Ozols E, Atkins RC, Rollin BJ, Tesch GH: Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 69: 73-80, 2006
-
(2006)
Kidney Int
, vol.69
, pp. 73-80
-
-
Chow, F.Y.1
Nikolic-Paterson, D.J.2
Ozols, E.3
Atkins, R.C.4
Rollin, B.J.5
Tesch, G.H.6
-
26
-
-
0036717048
-
Role of nephrin in renal disease including diabetic nephropathy
-
Cooper ME, Mundel P, Boner G: Role of nephrin in renal disease including diabetic nephropathy. Semin Nephrol 22: 393-398, 2002
-
(2002)
Semin Nephrol
, vol.22
, pp. 393-398
-
-
Cooper, M.E.1
Mundel, P.2
Boner, G.3
-
27
-
-
79959439429
-
Dedifferentiation of immortalized human podocytes in response to transforming growth factor-b: A model for diabetic podocytopathy
-
Herman-EdelsteinM, ThomasMC, Thallas-Bonke V, SaleemM, Cooper ME, Kantharidis P: Dedifferentiation of immortalized human podocytes in response to transforming growth factor-b: A model for diabetic podocytopathy. Diabetes 60: 1779-1788, 2011
-
(2011)
Diabetes
, vol.60
, pp. 1779-1788
-
-
Herman-Edelstein, M.1
Thomas, M.C.2
Thallas-Bonke, V.3
Saleem, M.4
Cooper, M.E.5
Kantharidis, P.6
-
28
-
-
84887060616
-
Genetic deletion ofCDA1 retards diabetes associated renal injury
-
Chai Z, Dai A, Tu Y, Li J, Wu T, Wang Y, Hale LJ, Koentgen F, Thomas MC,CooperME:Genetic deletion ofCDA1 retards diabetes associated renal injury. J Am Soc Nephrol 24: 1782-1792, 2013
-
(2013)
J Am Soc Nephrol
, vol.24
, pp. 1782-1792
-
-
Chai, Z.1
Dai, A.2
Tu, Y.3
Li, J.4
Wu, T.5
Wang, Y.6
Hale, L.J.7
Koentgen, F.8
Thomas, M.C.9
Cooper, M.E.10
-
29
-
-
3543148984
-
Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: Role of advanced glycation end products
-
Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA: Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: Role of advanced glycation end products. J AmSoc Nephrol 15: 2125-2138, 2004
-
(2004)
J AmSoc Nephrol
, vol.15
, pp. 2125-2138
-
-
Lassila, M.1
Seah, K.K.2
Allen, T.J.3
Thallas, V.4
Thomas, M.C.5
Candido, R.6
Burns, W.C.7
Forbes, J.M.8
Calkin, A.C.9
Cooper, M.E.10
Jandeleit-Dahm, K.A.11
-
30
-
-
84864360259
-
The NOX toolbox: Validating the role of NADPH oxidases in physiology and disease
-
Altenhöfer S, Kleikers PW, Radermacher KA, Scheurer P, Rob Hermans JJ, Schiffers P, Ho H, Wingler K, Schmidt HH: The NOX toolbox: Validating the role of NADPH oxidases in physiology and disease. Cell Mol Life Sci 69: 2327-2343, 2012
-
(2012)
Cell Mol Life Sci
, vol.69
, pp. 2327-2343
-
-
Altenhöfer, S.1
Kleikers, P.W.2
Radermacher, K.A.3
Scheurer, P.4
Rob Hermans, J.J.5
Schiffers, P.6
Ho, H.7
Wingler, K.8
Schmidt, H.H.9
-
31
-
-
77956813371
-
Comparative pharmacology of chemically distinct NADPH oxidase inhibitors
-
Wind S, Beuerlein K, Eucker T, Müller H, Scheurer P, Armitage ME, Ho H, Schmidt HH, Wingler K: Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br J Pharmacol 161: 885-898, 2010
-
(2010)
Br J Pharmacol
, vol.161
, pp. 885-898
-
-
Wind, S.1
Beuerlein, K.2
Eucker, T.3
Müller, H.4
Scheurer, P.5
Armitage, M.E.6
Ho, H.7
Schmidt, H.H.8
Wingler, K.9
-
32
-
-
34547743999
-
Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice
-
Fujii M, Inoguchi T, Maeda Y, Sasaki S, Sawada F, Saito R, Kobayashi K, Sumimoto H, Takayanagi R: Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice. Kidney Int 72: 473-480, 2007
-
(2007)
Kidney Int
, vol.72
, pp. 473-480
-
-
Fujii, M.1
Inoguchi, T.2
Maeda, Y.3
Sasaki, S.4
Sawada, F.5
Saito, R.6
Kobayashi, K.7
Sumimoto, H.8
Takayanagi, R.9
-
33
-
-
84881008965
-
ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice
-
Ford BM, Eid AA, Göoz M, Barnes JL, Gorin YC, Abboud HE: ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice. Am J Physiol Renal Physiol 305: F323-F332, 2013
-
(2013)
Am J Physiol Renal Physiol
, vol.305
, pp. F323-F332
-
-
Ford, B.M.1
Eid, A.A.2
Göoz, M.3
Barnes, J.L.4
Gorin, Y.C.5
Abboud, H.E.6
-
34
-
-
77955629280
-
Susceptible mice: Identifying a diabetic nephropathy disease locus using a murine model
-
Brosius FC: Susceptible mice: Identifying a diabetic nephropathy disease locus using a murine model. Kidney Int 78: 431-432, 2010
-
(2010)
Kidney Int
, vol.78
, pp. 431-432
-
-
Brosius, F.C.1
-
35
-
-
75149174337
-
NAD(P)Hoxidase mediates TGF-beta1-induced activation of kidney myofibroblasts
-
Bondi CD, Manickam N, Lee DY, Block K, Gorin Y, Abboud HE, Barnes JL:NAD(P)Hoxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol 21: 93-102, 2010
-
(2010)
J Am Soc Nephrol
, vol.21
, pp. 93-102
-
-
Bondi, C.D.1
Manickam, N.2
Lee, D.Y.3
Block, K.4
Gorin, Y.5
Abboud, H.E.6
Barnes, J.L.7
-
36
-
-
78649913769
-
Critical role of Nox4-basedNADPH oxidase in glucose-induced oxidative stress in the kidney: Implications in type 2 diabetic nephropathy
-
SedeekM, Callera G,Montezano A, Gutsol A, Heitz F, Szyndralewiez C, Page P, Kennedy CR, Burns KD, Touyz RM, Hébert RL: Critical role of Nox4-basedNADPH oxidase in glucose-induced oxidative stress in the kidney: Implications in type 2 diabetic nephropathy.Am J Physiol Renal Physiol 299: F1348-F1358, 2010
-
(2010)
Am J Physiol Renal Physiol
, vol.299
, pp. F1348-F1358
-
-
Sedeek, M.1
Callera, G.2
Montezano, A.3
Gutsol, A.4
Heitz, F.5
Szyndralewiez, C.6
Page, P.7
Kennedy, C.R.8
Burns, K.D.9
Touyz, R.M.10
Hébert, R.L.11
-
37
-
-
79954546899
-
High glucose concentration affects the oxidant-antioxidant balance in cultured mouse podocytes
-
Piwkowska A, Rogacka D, Audzeyenka I, JankowskiM, Angielski S:High glucose concentration affects the oxidant-antioxidant balance in cultured mouse podocytes. J Cell Biochem 112: 1661-1672, 2011
-
(2011)
J Cell Biochem
, vol.112
, pp. 1661-1672
-
-
Piwkowska, A.1
Rogacka, D.2
Audzeyenka, I.3
Jankowski, M.4
Angielski, S.5
-
38
-
-
0036789207
-
Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody
-
Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R: Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51: 3090-3094, 2002
-
(2002)
Diabetes
, vol.51
, pp. 3090-3094
-
-
Flyvbjerg, A.1
Dagnaes-Hansen, F.2
De Vriese, A.S.3
Schrijvers, B.F.4
Tilton, R.G.5
Rasch, R.6
-
39
-
-
77953200258
-
Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: Role of NADPH oxidase 4
-
Li J, Wang JJ, Yu Q, Chen K, Mahadev K, Zhang SX: Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: Role of NADPH oxidase 4. Diabetes 59: 1528-1538, 2010
-
(2010)
Diabetes
, vol.59
, pp. 1528-1538
-
-
Li, J.1
Wang, J.J.2
Yu, Q.3
Chen, K.4
Mahadev, K.5
Zhang, S.X.6
-
40
-
-
77956808539
-
Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration
-
Kleinschnitz C, Grund H, Wingler K, Armitage ME, Jones E, Mittal M, BaritD, Schwarz T,Geis C, Kraft P, Barthel K, SchuhmannMK,Herrmann AM, Meuth SG, Stoll G, Meurer S, Schrewe A, Becker L, Gailus-Durner V, Fuchs H, Klopstock T, de Angelis MH, Jandeleit-Dahm K, Shah AM, Weissmann N, Schmidt HH: Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol 8: 8, 2010
-
(2010)
PLoS Biol
, vol.8
, pp. 8
-
-
Kleinschnitz, C.1
Grund, H.2
Wingler, K.3
Armitage, M.E.4
Jones, E.5
Mittal, M.6
Barit, D.7
Schwarz, T.8
Geis, C.9
Kraft, P.10
Barthel, K.11
Schuhmann, M.K.12
Herrmann, A.M.13
Meuth, S.G.14
Stoll, G.15
Meurer, S.16
Schrewe, A.17
Becker, L.18
Gailus-Durner, V.19
Fuchs, H.20
Klopstock, T.21
De Angelis, M.H.22
Jandeleit-Dahm, K.23
Shah, A.M.24
Weissmann, N.25
Schmidt, H.H.26
more..
-
41
-
-
33750519444
-
Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells
-
Park HS, Chun JN, Jung HY, Choi C, Bae YS: Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells. Cardiovasc Res 72: 447-455, 2006
-
(2006)
Cardiovasc Res
, vol.72
, pp. 447-455
-
-
Park, H.S.1
Chun, J.N.2
Jung, H.Y.3
Choi, C.4
Bae, Y.S.5
-
42
-
-
0141755317
-
Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: Potential role in diabetic nephropathy
-
Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Senokuchi T, Matsuo T, Matsumura T, Tokunaga H, Brownlee M, Araki E: Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: Potential role in diabetic nephropathy. Diabetes 52: 2570-2577, 2003
-
(2003)
Diabetes
, vol.52
, pp. 2570-2577
-
-
Kiritoshi, S.1
Nishikawa, T.2
Sonoda, K.3
Kukidome, D.4
Senokuchi, T.5
Matsuo, T.6
Matsumura, T.7
Tokunaga, H.8
Brownlee, M.9
Araki, E.10
-
43
-
-
0034643340
-
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
-
Nishikawa T, Edelstein D, Du XL, Yamagishi S,Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000
-
(2000)
Nature
, vol.404
, pp. 787-790
-
-
Nishikawa, T.1
Edelstein, D.2
Du, X.L.3
Yamagishi, S.4
Matsumura, T.5
Kaneda, Y.6
Yorek, M.A.7
Beebe, D.8
Oates, P.J.9
Hammes, H.P.10
Giardino, I.11
Brownlee, M.12
-
44
-
-
0037974569
-
Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression
-
Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS: Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124, 2003
-
(2003)
Am J Physiol Regul Integr Comp Physiol
, vol.285
, pp. R117-R124
-
-
Chabrashvili, T.1
Kitiyakara, C.2
Blau, J.3
Karber, A.4
Aslam, S.5
Welch, W.J.6
Wilcox, C.S.7
-
45
-
-
0942287120
-
The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats
-
Nishiyama A, Yoshizumi M, Hitomi H, Kagami S, Kondo S, Miyatake A, FukunagaM, TamakiT, KiyomotoH, KohnoM,Shokoji T, KimuraS, Abe Y: The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats. J Am Soc Nephrol 15: 306-315, 2004
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 306-315
-
-
Nishiyama, A.1
Yoshizumi, M.2
Hitomi, H.3
Kagami, S.4
Kondo, S.5
Miyatake, A.6
Fukunaga, M.7
Tamaki, T.8
Kiyomoto, H.9
Kohno, M.10
Shokoji, T.11
Kimura, S.12
Abe, Y.13
-
46
-
-
34047247353
-
The renin-angiotensin system and diabetic nephropathy
-
Gurley SB, Coffman TM: The renin-angiotensin system and diabetic nephropathy. Semin Nephrol 27: 144-152, 2007
-
(2007)
Semin Nephrol
, vol.27
, pp. 144-152
-
-
Gurley, S.B.1
Coffman, T.M.2
-
47
-
-
85006847162
-
Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy
-
Kobori H, Kamiyama M, Harrison-Bernard LM, Navar LG: Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy. J InvestigMed 61: 256-264, 2013
-
(2013)
J InvestigMed
, vol.61
, pp. 256-264
-
-
Kobori, H.1
Kamiyama, M.2
Harrison-Bernard, L.M.3
Navar, L.G.4
-
48
-
-
84864571088
-
Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smoothmuscle cell migration and proliferation through AT1, Nox1, and interleukin-18
-
Valente AJ, Yoshida T, Murthy SN, Sakamuri SS, Katsuyama M, Clark RA, Delafontaine P, Chandrasekar B: Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smoothmuscle cell migration and proliferation through AT1, Nox1, and interleukin-18. Am J Physiol Heart Circ Physiol 303: H282-H296, 2012
-
(2012)
Am J Physiol Heart Circ Physiol
, vol.303
, pp. H282-H296
-
-
Valente, A.J.1
Yoshida, T.2
Murthy, S.N.3
Sakamuri, S.S.4
Katsuyama, M.5
Clark, R.A.6
Delafontaine, P.7
Chandrasekar, B.8
-
50
-
-
84878252198
-
Role of Nox2 in diabetic kidney disease
-
You YH,Okada S, Ly S, Jandeleit-DahmK, BaritD,Namikoshi T, Sharma K: Role of Nox2 in diabetic kidney disease. Am J Physiol Renal Physiol 304: F840-F848, 2013
-
(2013)
Am J Physiol Renal Physiol
, vol.304
, pp. F840-F848
-
-
You, Y.H.1
Okada, S.2
Ly, S.3
Jandeleit-Dahm, K.4
Barit, D.5
Namikoshi, T.6
Sharma, K.7
-
51
-
-
84866068439
-
TouyzRM: Oxidative stress, Nox isoforms and complications of diabetes-potential targets for novel therapies
-
Sedeek M, Montezano AC, Hebert RL, Gray SP, Di Marco E, Jha JC, CooperME, Jandeleit-DahmK, Schiffrin EL,Wilkinson-Berka JL, TouyzRM: Oxidative stress, Nox isoforms and complications of diabetes-potential targets for novel therapies. J Cardiovasc Transl Res 5: 509-518, 2012
-
(2012)
J Cardiovasc Transl Res
, vol.5
, pp. 509-518
-
-
Sedeek, M.1
Montezano, A.C.2
Hebert, R.L.3
Gray, S.P.4
Di Marco, E.5
Jha, J.C.6
Cooper, M.E.7
Jandeleit-Dahm, K.8
Schiffrin, E.L.9
Wilkinson-Berka, J.L.10
-
52
-
-
84862290446
-
Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo
-
Jiang JX, Chen X, Serizawa N, Szyndralewiez C, Page P, Schröder K, Brandes RP, Devaraj S, Török NJ: Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol Med 53: 289-296, 2012
-
(2012)
Free Radic Biol Med
, vol.53
, pp. 289-296
-
-
Jiang, J.X.1
Chen, X.2
Serizawa, N.3
Szyndralewiez, C.4
Page, P.5
Schröder, K.6
Brandes, R.P.7
Devaraj, S.8
Török, N.J.9
-
53
-
-
30644458693
-
Decreased blood pressure in NOX1-deficientmice
-
Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, Krause KH: Decreased blood pressure in NOX1-deficientmice. FEBS Lett 580: 497-504, 2006
-
(2006)
FEBS Lett
, vol.580
, pp. 497-504
-
-
Gavazzi, G.1
Banfi, B.2
Deffert, C.3
Fiette, L.4
Schappi, M.5
Herrmann, F.6
Krause, K.H.7
-
54
-
-
79958011291
-
Role for Nox1 NADPH oxidase in atherosclerosis
-
Sheehan AL, Carrell S, Johnson B, Stanic B, Banfi B, Miller FJ Jr: Role for Nox1 NADPH oxidase in atherosclerosis. Atherosclerosis 216: 321-326, 2011
-
(2011)
Atherosclerosis
, vol.216
, pp. 321-326
-
-
Sheehan, A.L.1
Carrell, S.2
Johnson, B.3
Stanic, B.4
Banfi, B.5
Miller, F.J.6
-
55
-
-
78149268561
-
First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis
-
Laleu B, Gaggini F, Orchard M, Fioraso-Cartier L, Cagnon L, Houngninou-Molango S, Gradia A, Duboux G, Merlot C, Heitz F, Szyndralewiez C, Page P: First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J Med Chem53: 7715-7730, 2010
-
(2010)
J Med Chem
, vol.53
, pp. 7715-7730
-
-
Laleu, B.1
Gaggini, F.2
Orchard, M.3
Fioraso-Cartier, L.4
Cagnon, L.5
Houngninou-Molango, S.6
Gradia, A.7
Duboux, G.8
Merlot, C.9
Heitz, F.10
Szyndralewiez, C.11
Page, P.12
-
56
-
-
72449124626
-
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein e knockout mice
-
Watson AM, Li J, Schumacher C, de Gasparo M, Feng B, Thomas MC, Allen TJ, Cooper ME, Jandeleit-Dahm KA: The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice. Diabetologia 53: 192-203, 2010
-
(2010)
Diabetologia
, vol.53
, pp. 192-203
-
-
Watson, A.M.1
Li, J.2
Schumacher, C.3
De Gasparo, M.4
Feng, B.5
Thomas, M.C.6
Allen, T.J.7
Cooper, M.E.8
Jandeleit-Dahm, K.A.9
-
57
-
-
0029006463
-
A noninvasive computerized tail-cuff system for measuring blood pressure in mice
-
Krege JH, Hodgin JB, Hagaman JR, Smithies O: A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 25: 1111-1115, 1995
-
(1995)
Hypertension
, vol.25
, pp. 1111-1115
-
-
Krege, J.H.1
Hodgin, J.B.2
Hagaman, J.R.3
Smithies, O.4
-
58
-
-
84864386296
-
Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein e knockout mice
-
Watson AM, Gray SP, Jiaze L, Soro-Paavonen A, Wong B, Cooper ME, Bierhaus A, Pickering R, Tikellis C, Tsorotes D, Thomas MC, Jandeleit-Dahm KA: Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice. Diabetes 61: 2105-2113, 2012
-
(2012)
Diabetes
, vol.61
, pp. 2105-2113
-
-
Watson, A.M.1
Gray, S.P.2
Jiaze, L.3
Soro-Paavonen, A.4
Wong, B.5
Cooper, M.E.6
Bierhaus, A.7
Pickering, R.8
Tikellis, C.9
Tsorotes, D.10
Thomas, M.C.11
Jandeleit-Dahm, K.A.12
-
59
-
-
33750126963
-
PPAR-alpha and-gamma agonists attenuate diabetic kidney disease in the apolipoprotein e knockout mouse
-
Calkin AC, Giunti S, Jandeleit-Dahm KA, Allen TJ, Cooper ME, Thomas MC: PPAR-alpha and-gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse. Nephrol Dial Transplant 21: 2399-2405, 2006
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 2399-2405
-
-
Calkin, A.C.1
Giunti, S.2
Jandeleit-Dahm, K.A.3
Allen, T.J.4
Cooper, M.E.5
Thomas, M.C.6
-
60
-
-
0036189998
-
A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression
-
SaleemMA,O'HareMJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, Mundel P: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13: 630-638, 2002
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 630-638
-
-
Saleem, M.A.1
O'hare, M.J.2
Reiser, J.3
Coward, R.J.4
Inward, C.D.5
Farren, T.6
Xing, C.Y.7
Ni, L.8
Mathieson, P.W.9
Mundel, P.10
-
61
-
-
84863393198
-
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells
-
Okabe J,Orlowski C, Balcerczyk A, Tikellis C, Thomas MC, CooperME, El-Osta A: Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells. Circ Res 110: 1067-1076, 2012
-
(2012)
Circ Res
, vol.110
, pp. 1067-1076
-
-
Okabe Jorlowski, C.1
Balcerczyk, A.2
Tikellis, C.3
Thomas, M.C.4
Cooperme El-Osta, A.5
|